We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

The Effect of Ambient Oxygen Tension on the Toxicity and Therapeutic Effect of Mechlorethamine (Nitrogen Mustard)

Arch Surg. 1963;86(6):932-939. doi:10.1001/archsurg.1963.01310120050009.
Text Size: A A A
Published online


Introduction  Present research in the chemotherapy of malignant disease has followed two general patterns. The first and most extensively pursued has been attempts to discover new and better therapeutic agents. The second approach has been attempts to develop methods of increasing the therapeutic effectiveness of the presently available agents by trying to decrease their systemic toxicity or to increase their therapeutic ratio. Mechlorethamine (nitrogen mustard), the oldest of the present day chemotherapeutic agents, has been the most intensively studied with this latter objective in mind.Klopp1 first demonstrated an increase in therapeutic effect and at the same time a decrease in systemic toxicity of mechlorethamine when it was administered by the intra-arterial rather than the intravenous route. This was almost simultaneously confirmed by Bierman et al.2 Several recent investigators have reported attempts to reduce the systemic toxicity of mechlorethamine by the simultaneous infusion of cysteine or thiosulfate solutions.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.